On 9 November 2021, J.J. van den Driest will defend her PhD dissertation, entitled: ‘Medication for Osteoarthritis Pain. Use and evidence for opioids and neuropathic pain medication’.
- Promotor
- Promotor
- Associate professor
- Date
- Tuesday 9 Nov 2021, 13:00 - 14:30
- Type
- PhD defence
- Space
- Professor Andries Querido room
- Building
- Education Center
- Location
- Erasmus MC
Osteoarthritis (OA) is a chronic disease of the musculoskeletal system. Pain and disability are two important complaints of patients with OA. The treatment options are education, dietary advice and weight loss, physiotherapy and analgesics. The currently prescribed analgesics do not always reduce pain sufficiently, can have side-effects or can be contra-indicated. An alternative may be the use of neuropathic pain medication. The alternative that has been studied most extensively for OA pain is duloxetine, an antidepressant. Small to moderate effects are found in placebo-controlled trials. The aim of the current thesis was 1) to provide insight into the current prescription rates and use of opioids and neuropathic pain medication in patients with OA and 2) to assess the effectiveness of duloxetine added to usual care compared to usual care alone for patients with chronic pain due to hip or knee OA in primary care.
The public defence will take place at the Prof. Andries Queridoroom, 3rd floor Education Center, Erasmus MC. The ceremony will begin exactly at 13.00 PM. In light of the solemn nature of the ceremony, we recommend that you do not take children under the age of 6 to the first part of the ceremony.
